AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32701836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 35379559 — intervention group
Group type: COMPARATOR
Intervention: Adherent comparator pharmacies (true control)
Number of subjects: 24
Study 35379559 — intervention group
Group type: COMPARATOR
Intervention: Non-adherent comparator pharmacies
Number of subjects: 24
Study 33667246 — intervention group
Group type: EXPERIMENTAL
Intervention: Google Classroom (GC) integrated with traditional teaching, 1 hour of GC and 1 hour of traditional teaching per week for 15 weeks.
Number of subjects: 74
Study 33667246 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching only, 2 hours per week for 15 weeks.
Number of subjects: 74
Study 34581239 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 76
Study 34581239 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary Behaviour (SB)
Number of subjects: 76
Study 33373683 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic Bankart repair with remplissage (REMP)
Number of subjects: 108
Study 33373683 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic Bankart repair without remplissage (NO REMP)
Number of subjects: 108
Study 33373683 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 108
Study 35113294 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face, group-based program (OVK)
Number of subjects: 190
Study 35113294 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized, individual program (SPARX)
Number of subjects: 190
Study 35113294 — intervention group
Group type: EXPERIMENTAL
Intervention: OVK and SPARX combined
Number of subjects: 190
Study 35113294 — intervention group
Group type: COMPARATOR
Intervention: Monitoring control condition
Number of subjects: 190
Study 35113294 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall sample
Number of subjects: 190
Study 33992687 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitric oxide nasal spray (NONS)
Number of subjects: 80
Study 33992687 — intervention group
Group type: COMPARATOR
Intervention: Saline spray (control)
Number of subjects: 80
Study 34936174 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy Group Intervention targeting Repetitive Negative Thinking (RNT-G)
Number of subjects: 80
Study 33910614 — intervention group
Group type: EXPERIMENTAL
Intervention: ARBOX (390 mg) administered as 2 capsules per day for 14 days
Number of subjects: 140
Study 33910614 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered for 14 days
Number of subjects: 140
Study 70529819 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guided rectus sheath block
Number of subjects: 30
Study 70529819 — intervention group
Group type: COMPARATOR
Intervention: Wound infiltration
Number of subjects: 30
Study 35426602 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical trial participants with non-paroxysmal AF (non-pAF)
Number of subjects: 5917
Study 35426602 — intervention group
Group type: COMPARATOR
Intervention: Real-world patients
Number of subjects: 5917
Study 35426602 — intervention group
Group type: EXPERIMENTAL
Intervention: AF type (non-pAF vs. pAF) in clinical trial cohort
Number of subjects: 5917
Study 35426602 — intervention group
Group type: EXPERIMENTAL
Intervention: AF type (non-pAF vs. pAF) in real-world cohort
Number of subjects: 5917
Study 35426602 — intervention group
Group type: EXPERIMENTAL
Intervention: CHA2DS2-VAS‘c’ score
Number of subjects: 5917
Study 33131986 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital templates (DT)
Number of subjects: 61
Study 33131986 — intervention group
Group type: COMPARATOR
Intervention: Conventional resin occlusal splint (CROS)
Number of subjects: 61
Study 33131986 — intervention group
Group type: COMPARATOR
Intervention: Digital occlusal splint (DOS)
Number of subjects: 61
Study 35235870 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 1034
Study 35235870 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin
Number of subjects: 1034
Study 35235870 — intervention group
Group type: COMPARATOR
Intervention: Localised cancer (Control)
Number of subjects: 1034
Study 32561489 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure reduction
Number of subjects: 992
Study 32561489 — intervention group
Group type: COMPARATOR
Intervention: Standard systolic blood pressure reduction
Number of subjects: 992
Study 32181609 — intervention group
Group type: EXPERIMENTAL
Intervention: Propulseur universal light (PUL) appliance
Number of subjects: 26
Study 32181609 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 26
Study 35809896 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamicin (GO) combined with post-induction chemotherapy
Number of subjects: 0
Study 35809896 — intervention group
Group type: COMPARATOR
Intervention: Non-GO arm (control)
Number of subjects: 0
Study 33846728 — intervention group
Group type: EXPERIMENTAL
Intervention: AUT (automatic) annotation protocol
Number of subjects: 100
Study 33846728 — intervention group
Group type: COMPARATOR
Intervention: MAN (manual) annotation protocol
Number of subjects: 100
Study 35513159 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 26
Study 35513159 — intervention group
Group type: COMPARATOR
Intervention: Best medical treatment
Number of subjects: 26
Study 34780478 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus etoposide-platinum (EP)
Number of subjects: 0
Study 34780478 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus etoposide-platinum (EP)
Number of subjects: 0
Study 33502809 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable polymer DES (Firehawk)
Number of subjects: 1296
Study 33502809 — intervention group
Group type: COMPARATOR
Intervention: Durable polymer DES (XIENCE)
Number of subjects: 1296
Study 35924803 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 0.5 μg/kg
Number of subjects: 64
Study 35924803 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 1.0 μg/kg
Number of subjects: 64
Study 35924803 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 64
Study 35640116 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet intervention (hypocaloric diet of 1000-1500 kcal/day and high protein meal replacements)
Number of subjects: 40
Study 35640116 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet intervention
Number of subjects: 40
Study 35640116 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 34016293 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-session marijuana check-up (MCU) intervention
Number of subjects: 186
Study 34016293 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-session marijuana check-up (MCU) intervention
Number of subjects: 186
Study 33270739 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar spine imaging (radiography, CT, MRI)
Number of subjects: 13458
Study 33270739 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiography
Number of subjects: 13458
Study 33270739 — intervention group
Group type: EXPERIMENTAL
Intervention: CT and MRI
Number of subjects: 13458
Study 33270739 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported back pain
Number of subjects: 13458
Study 33270739 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimated costs for lumbar spine imaging
Number of subjects: 13458
Study 33625162 — intervention group
Group type: EXPERIMENTAL
Intervention: Docusate sodium
Number of subjects: 107
Study 33625162 — intervention group
Group type: EXPERIMENTAL
Intervention: Senna glycoside
Number of subjects: 107
Study 33625162 — intervention group
Group type: COMPARATOR
Intervention: Control (nothing)
Number of subjects: 107
Study 32370774 — intervention group
Group type: EXPERIMENTAL
Intervention: Pillbox-enabled self-administered therapy (SAT) with HRZE fixed-dose combination therapy for 15 days
Number of subjects: 144
Study 32370774 — intervention group
Group type: COMPARATOR
Intervention: Standard directly observed therapy (DOT)
Number of subjects: 144
Study 32370774 — intervention group
Group type: EXPERIMENTAL
Intervention: Pillbox-enabled self-administered therapy (SAT)
Number of subjects: 144
Study 35363330 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + PDT (test group)
Number of subjects: 60
Study 35363330 — intervention group
Group type: COMPARATOR
Intervention: SRP alone (control group)
Number of subjects: 60
Study 33021443 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrotal orchidopexy
Number of subjects: 161
Study 33021443 — intervention group
Group type: COMPARATOR
Intervention: Inguinal orchidopexy
Number of subjects: 161
Study 33021443 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 161
Study 32680556 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cancer recovery (MBCR)
Number of subjects: 0
Study 32680556 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai chi/Qigong (TCQ)
Number of subjects: 0
Study 32680556 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 0
Study 35037275 — intervention group
Group type: EXPERIMENTAL
Intervention: Male Athlete Body Project (MABP)
Number of subjects: 79
Study 35037275 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control condition
Number of subjects: 79
Study 34572743 — intervention group
Group type: EXPERIMENTAL
Intervention: HTP-CT
Number of subjects: 33
Study 34572743 — intervention group
Group type: COMPARATOR
Intervention: CT
Number of subjects: 33
Study 32795544 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronabinol therapy
Number of subjects: 91
Study 32795544 — intervention group
Group type: COMPARATOR
Intervention: Cannabis use
Number of subjects: 91
Study 36207867 — intervention group
Group type: EXPERIMENTAL
Intervention: Gap Balancing (GB) technique
Number of subjects: 57
Study 36207867 — intervention group
Group type: COMPARATOR
Intervention: Measured Resection (MR) technique
Number of subjects: 57
Study 34161982 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients' strategies to address physical problems after hospitalization.
Number of subjects: 46
Study 34161982 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients' strategies to address cognitive problems after hospitalization.
Number of subjects: 46
Study 34161982 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients' strategies to address emotional problems after hospitalization.
Number of subjects: 46
Study 34161982 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support and previous familiarity with the health care system.
Number of subjects: 46
Study 34161982 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent problems after ARDS.
Number of subjects: 46
Study 32302671 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother and Child Education Program (MOECP)
Number of subjects: 0
Study 32302671 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34039352 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant HIPEC
Number of subjects: 0
Study 35403395 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive group (simultaneous electroacupuncture at antagonistic and agonistic muscles)
Number of subjects: 60
Study 35403395 — intervention group
Group type: COMPARATOR
Intervention: Antagonistic muscle group (simple electroacupuncture at antagonistic muscle)
Number of subjects: 60
Study 33452200 — intervention group
Group type: EXPERIMENTAL
Intervention: Instantaneous wave-free ratio guided treatment of non-culprit lesions during the index procedure
Number of subjects: 0
Study 33452200 — intervention group
Group type: COMPARATOR
Intervention: Deferred cardiac MR-guided management within 4 days to 6 weeks
Number of subjects: 0
Study 32871917 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor canal block combined with local infiltration analgesia
Number of subjects: 72
Study 32871917 — intervention group
Group type: COMPARATOR
Intervention: Adductor canal block alone
Number of subjects: 72
Study 36150665 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous auricular vagus nerve stimulation (taVNS)
Number of subjects: 52
Study 36150665 — intervention group
Group type: COMPARATOR
Intervention: Sham taVNS
Number of subjects: 52
Study 32029493 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial cervical plexus block
Number of subjects: 0
Study 32029493 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 36494834 — intervention group
Group type: EXPERIMENTAL
Intervention: focal HDR brachytherapy boost (fBT) of 13–15 Gy in 1 fraction followed by stereotactic radiotherapy (sRT) 36.25‐40 Gy in 5 fractions
Number of subjects: 150
Study 36494834 — intervention group
Group type: COMPARATOR
Intervention: standard-of-care (SOC) high dose rate (HDR) brachytherapy boost to radiotherapy (RT)
Number of subjects: 150
Study 36494834 — intervention group
Group type: EXPERIMENTAL
Intervention: focal HDR brachytherapy boost (fBT)
Number of subjects: 150
Study 34412658 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital healthcare system rehabilitation (intervention)
Number of subjects: 100
Study 34412658 — intervention group
Group type: COMPARATOR
Intervention: Brochure-based rehabilitation (control)
Number of subjects: 100
Study 33788485 — intervention group
Group type: EXPERIMENTAL
Intervention: Thumbtack needling therapy
Number of subjects: 120
Study 33788485 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (thumbtack needling + external treatment)
Number of subjects: 120
Study 33788485 — intervention group
Group type: COMPARATOR
Intervention: External treatment (shangshi zhitong plaster)
Number of subjects: 120
Study 35648044 — intervention group
Group type: EXPERIMENTAL
Intervention: Kikyo-to (Kt) 2500 mg
Number of subjects: 70
Study 35648044 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose) 2500 mg
Number of subjects: 70
Study 33932320 — intervention group
Group type: EXPERIMENTAL
Intervention: internet-based attention bias modification (iABM), 5 sessions over 1 month
Number of subjects: 300
Study 33932320 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 300
Study 33892754 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic gait training targeting paretic propulsion (ten 60‐min sessions, five weeks, twice a week)
Number of subjects: 29
Study 33892754 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic gait training targeting paretic propulsion
Number of subjects: 29
Study 616875265 — intervention group
Group type: EXPERIMENTAL
Intervention: Nominal monetary incentive during or 1 month after the stay
Number of subjects: 285
Study 35350436 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir/Levonorgestrel Vaginal Ring (IVR)
Number of subjects: 47
Study 35350436 — intervention group
Group type: COMPARATOR
Intervention: Placebo IVR
Number of subjects: 47
Study 33517746 — intervention group
Group type: EXPERIMENTAL
Intervention: Online education programme (ED)
Number of subjects: 1024
Study 33517746 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact through simulated contact with people with dementia and carers (CT)
Number of subjects: 1024
Study 33517746 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and contact (ED+CT)
Number of subjects: 1024
Study 33517746 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 1024
Study 35713504 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-reopening abortion care services
Number of subjects: 0
Study 35713504 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-reopening abortion care clients
Number of subjects: 0
Study 35713504 — intervention group
Group type: COMPARATOR
Intervention: Pre-closure abortion care services
Number of subjects: 0
Study 32169363 — intervention group
Group type: EXPERIMENTAL
Intervention: Gliadel Wafer and DC vaccination
Number of subjects: 28
Study 32169363 — intervention group
Group type: EXPERIMENTAL
Intervention: DC vaccination
Number of subjects: 28
Study 32169363 — intervention group
Group type: EXPERIMENTAL
Intervention: Gliadel Wafer placement
Number of subjects: 28
Study 35144699 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (FO, 5.2 g/d n‐3PUFA)
Number of subjects: 26
Study 34429095 — intervention group
Group type: EXPERIMENTAL
Intervention: Do not interrupt vest (experimental group)
Number of subjects: 178
Study 34429095 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vest)
Number of subjects: 178
Study 35500961 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic lumbar motor control training (MCT) for 8 weeks
Number of subjects: 19
Study 35500961 — intervention group
Group type: COMPARATOR
Intervention: General trunk-training for 8 weeks
Number of subjects: 19
Study 35500961 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic lumbar motor control training (MCT)
Number of subjects: 19
Study 35500961 — intervention group
Group type: COMPARATOR
Intervention: General trunk-training
Number of subjects: 19
Study 32293517 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 100
Study 32293517 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 100
Study 32293517 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Hypnosis (VRH)
Number of subjects: 100
Study 32293517 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study 33927251 — intervention group
Group type: EXPERIMENTAL
Intervention: Large reward
Number of subjects: 0
Study 33927251 — intervention group
Group type: EXPERIMENTAL
Intervention: Reward
Number of subjects: 0
Study 33927251 — intervention group
Group type: COMPARATOR
Intervention: Punishment
Number of subjects: 0
Study 34287673 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline chloride
Number of subjects: 6
Study 34287673 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline bitartrate
Number of subjects: 6
Study 34287673 — intervention group
Group type: EXPERIMENTAL
Intervention: α‐glycerophosphocholine (GPC)
Number of subjects: 6
Study 34287673 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg-PC
Number of subjects: 6
Study 34287673 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 6
Study 33482387 — intervention group
Group type: EXPERIMENTAL
Intervention: VOM ethanol infusion combined with catheter ablation (CA)
Number of subjects: 343
Study 33482387 — intervention group
Group type: COMPARATOR
Intervention: CA alone
Number of subjects: 343
Study 33482387 — intervention group
Group type: EXPERIMENTAL
Intervention: VOM ethanol infusion combined with CA
Number of subjects: 343
Study 34871514 — intervention group
Group type: EXPERIMENTAL
Intervention: Open lung ventilation strategy
Number of subjects: 40
Study 34871514 — intervention group
Group type: COMPARATOR
Intervention: Standard ventilation
Number of subjects: 40
Study 34590746 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily omeprazole (1 mg/kg)
Number of subjects: 14
Study 35430521 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives of unspecified amount
Number of subjects: 635
Study 35430521 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives of $20
Number of subjects: 635
Study 35430521 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives of $60
Number of subjects: 635
Study 35430521 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives of $100
Number of subjects: 635
Study 35430521 — intervention group
Group type: EXPERIMENTAL
Intervention: Entire incentive at first clinical visit
Number of subjects: 635
Study 35430521 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with entire incentive at first clinic visit
Number of subjects: 635
Study 33863352 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-P13 SC
Number of subjects: 949
Study 32963266 — intervention group
Group type: EXPERIMENTAL
Intervention: NGF + lidocaine
Number of subjects: 60
Study 32963266 — intervention group
Group type: COMPARATOR
Intervention: NGF + IS
Number of subjects: 60
Study 32963266 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (IS)
Number of subjects: 60
Study 34306601 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart medical nursing intervention
Number of subjects: 80
Study 34306601 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing method (Control)
Number of subjects: 80
Study 33038502 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanifibranor (800 and 1200 mg/day)
Number of subjects: 0
Study 33038502 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35771621 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based brief alcohol intervention consisting of 3 individualized feedback letters sent via mail at baseline, month 3, and month 6.
Number of subjects: 1646
Study 35771621 — intervention group
Group type: COMPARATOR
Intervention: Assessment only (control group)
Number of subjects: 1646
Study 34408110 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravascular laser irradiation of blood (ILIB) for 10 min
Number of subjects: 84
Study 34408110 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser acupuncture for 40 s over points VG20 (Baihui), PC6 (Neiguan), and the Oppression Point
Number of subjects: 84
Study 34408110 — intervention group
Group type: COMPARATOR
Intervention: Sham laser irradiation of three acupuncture points
Number of subjects: 84
Study 34881670 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional resistance/balance training (3 days/week) during phase‐II CR and telephone‐support program during 3-month follow‐up.
Number of subjects: 116
Study 34881670 — intervention group
Group type: COMPARATOR
Intervention: Usual CR care.
Number of subjects: 116
Study 32083990 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 75 mg/m2 intravenously plus oral capecitabine 825 mg/m2 two times per day for 14 days every 3 weeks for 6 cycles (DC)
Number of subjects: 1301
Study 32083990 — intervention group
Group type: COMPARATOR
Intervention: Standard anthracycline-based regimens, with or without taxanes (control)
Number of subjects: 1301
Study 32083990 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel-capecitabine (DC)
Number of subjects: 1301
Study 32083990 — intervention group
Group type: COMPARATOR
Intervention: Standard anthracycline-based regimens (control)
Number of subjects: 1301
Study 35008008 — intervention group
Group type: EXPERIMENTAL
Intervention: SCIG 20% biweekly (dose adjustment factor 1.0 or 1.37)
Number of subjects: 95
Study 35008008 — intervention group
Group type: EXPERIMENTAL
Intervention: SCIG 20% weekly and biweekly
Number of subjects: 95